| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-09 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.24 | 8e-06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.32 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |